Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia
UPC Stock | USD 1.93 0.15 8.43% |
About 59% of all Universe Pharmaceuticals' shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Universe Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Universe Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Universe Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Universe |
Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com Investing.com Australia
Read at news.google.com
Universe Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Universe Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Universe Pharmaceuticals Fundamental Analysis
We analyze Universe Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Universe Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Universe Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Universe Pharmaceuticals is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Universe Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Universe Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Universe Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Universe Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Universe Pharmaceuticals Related Equities
PROC | Procaps Group | 7.95 | ||||
PAHC | Phibro Animal | 0.73 | ||||
RAPH | Raphael Pharmaceutical | 0.00 | ||||
RGC | Regencell Bioscience | 0.32 | ||||
SSIC | Silver Spike | 0.62 | ||||
TKNO | Alpha Teknova | 1.61 | ||||
IMCC | Im Cannabis | 22.81 |
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |